nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—AOX1—Methotrexate—lymphatic system cancer	0.313	0.544	CbGbCtD
Allopurinol—SLC22A7—Methotrexate—lymphatic system cancer	0.162	0.283	CbGbCtD
Allopurinol—SLC22A8—Methotrexate—lymphatic system cancer	0.0992	0.173	CbGbCtD
Allopurinol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000475	0.00112	CcSEcCtD
Allopurinol—Asthenia—Teniposide—lymphatic system cancer	0.00047	0.0011	CcSEcCtD
Allopurinol—Malaise—Bleomycin—lymphatic system cancer	0.000467	0.0011	CcSEcCtD
Allopurinol—Pruritus—Teniposide—lymphatic system cancer	0.000464	0.00109	CcSEcCtD
Allopurinol—Leukopenia—Bleomycin—lymphatic system cancer	0.000463	0.00109	CcSEcCtD
Allopurinol—Cardiac disorder—Vincristine—lymphatic system cancer	0.00046	0.00108	CcSEcCtD
Allopurinol—Alopecia—Carmustine—lymphatic system cancer	0.000459	0.00108	CcSEcCtD
Allopurinol—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000457	0.00107	CcSEcCtD
Allopurinol—Body temperature increased—Fludarabine—lymphatic system cancer	0.000455	0.00107	CcSEcCtD
Allopurinol—Mental disorder—Carmustine—lymphatic system cancer	0.000455	0.00107	CcSEcCtD
Allopurinol—Malnutrition—Carmustine—lymphatic system cancer	0.000452	0.00106	CcSEcCtD
Allopurinol—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000449	0.00106	CcSEcCtD
Allopurinol—Diarrhoea—Teniposide—lymphatic system cancer	0.000448	0.00105	CcSEcCtD
Allopurinol—Myalgia—Bleomycin—lymphatic system cancer	0.000441	0.00103	CcSEcCtD
Allopurinol—Alopecia—Vincristine—lymphatic system cancer	0.000438	0.00103	CcSEcCtD
Allopurinol—Coma—Methotrexate—lymphatic system cancer	0.000437	0.00103	CcSEcCtD
Allopurinol—Discomfort—Bleomycin—lymphatic system cancer	0.000435	0.00102	CcSEcCtD
Allopurinol—Mental disorder—Vincristine—lymphatic system cancer	0.000434	0.00102	CcSEcCtD
Allopurinol—Chills—Mitoxantrone—lymphatic system cancer	0.000433	0.00102	CcSEcCtD
Allopurinol—Ecchymosis—Methotrexate—lymphatic system cancer	0.000433	0.00102	CcSEcCtD
Allopurinol—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000428	0.00101	CcSEcCtD
Allopurinol—Alopecia—Mitoxantrone—lymphatic system cancer	0.000426	0.001	CcSEcCtD
Allopurinol—Confusional state—Bleomycin—lymphatic system cancer	0.000426	0.001	CcSEcCtD
Allopurinol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000424	0.000997	CcSEcCtD
Allopurinol—Tremor—Carmustine—lymphatic system cancer	0.000423	0.000994	CcSEcCtD
Allopurinol—Oedema—Bleomycin—lymphatic system cancer	0.000422	0.000992	CcSEcCtD
Allopurinol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000422	0.000992	CcSEcCtD
Allopurinol—Infection—Bleomycin—lymphatic system cancer	0.00042	0.000986	CcSEcCtD
Allopurinol—Anaemia—Carmustine—lymphatic system cancer	0.000417	0.000981	CcSEcCtD
Allopurinol—Vomiting—Teniposide—lymphatic system cancer	0.000417	0.000979	CcSEcCtD
Allopurinol—Sepsis—Methotrexate—lymphatic system cancer	0.000415	0.000976	CcSEcCtD
Allopurinol—Agitation—Carmustine—lymphatic system cancer	0.000415	0.000975	CcSEcCtD
Allopurinol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000413	0.000971	CcSEcCtD
Allopurinol—Asthenia—Fludarabine—lymphatic system cancer	0.000413	0.000971	CcSEcCtD
Allopurinol—Rash—Teniposide—lymphatic system cancer	0.000413	0.000971	CcSEcCtD
Allopurinol—Dermatitis—Teniposide—lymphatic system cancer	0.000413	0.00097	CcSEcCtD
Allopurinol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000411	0.000966	CcSEcCtD
Allopurinol—Headache—Teniposide—lymphatic system cancer	0.000411	0.000965	CcSEcCtD
Allopurinol—Pruritus—Fludarabine—lymphatic system cancer	0.000408	0.000957	CcSEcCtD
Allopurinol—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000407	0.000957	CcSEcCtD
Allopurinol—Leukopenia—Carmustine—lymphatic system cancer	0.000404	0.00095	CcSEcCtD
Allopurinol—Anorexia—Bleomycin—lymphatic system cancer	0.000403	0.000946	CcSEcCtD
Allopurinol—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000401	0.000943	CcSEcCtD
Allopurinol—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000399	0.000938	CcSEcCtD
Allopurinol—Anaemia—Vincristine—lymphatic system cancer	0.000399	0.000936	CcSEcCtD
Allopurinol—Agitation—Vincristine—lymphatic system cancer	0.000396	0.000931	CcSEcCtD
Allopurinol—Hypotension—Bleomycin—lymphatic system cancer	0.000395	0.000927	CcSEcCtD
Allopurinol—Diarrhoea—Fludarabine—lymphatic system cancer	0.000394	0.000926	CcSEcCtD
Allopurinol—Convulsion—Carmustine—lymphatic system cancer	0.000391	0.000919	CcSEcCtD
Allopurinol—Hypertension—Carmustine—lymphatic system cancer	0.00039	0.000916	CcSEcCtD
Allopurinol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00039	0.000915	CcSEcCtD
Allopurinol—Nausea—Teniposide—lymphatic system cancer	0.000389	0.000915	CcSEcCtD
Allopurinol—Anaemia—Mitoxantrone—lymphatic system cancer	0.000388	0.000912	CcSEcCtD
Allopurinol—Vertigo—Vincristine—lymphatic system cancer	0.000387	0.00091	CcSEcCtD
Allopurinol—Hepatic failure—Methotrexate—lymphatic system cancer	0.000387	0.000908	CcSEcCtD
Allopurinol—Leukopenia—Vincristine—lymphatic system cancer	0.000386	0.000907	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000385	0.000904	CcSEcCtD
Allopurinol—Myalgia—Carmustine—lymphatic system cancer	0.000385	0.000903	CcSEcCtD
Allopurinol—Paraesthesia—Bleomycin—lymphatic system cancer	0.000379	0.000891	CcSEcCtD
Allopurinol—Malaise—Mitoxantrone—lymphatic system cancer	0.000379	0.00089	CcSEcCtD
Allopurinol—Renal failure acute—Methotrexate—lymphatic system cancer	0.000376	0.000884	CcSEcCtD
Allopurinol—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000376	0.000883	CcSEcCtD
Allopurinol—Convulsion—Vincristine—lymphatic system cancer	0.000374	0.000878	CcSEcCtD
Allopurinol—Hypertension—Vincristine—lymphatic system cancer	0.000372	0.000875	CcSEcCtD
Allopurinol—Confusional state—Carmustine—lymphatic system cancer	0.000372	0.000873	CcSEcCtD
Allopurinol—Oedema—Carmustine—lymphatic system cancer	0.000369	0.000866	CcSEcCtD
Allopurinol—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000368	0.000865	CcSEcCtD
Allopurinol—Decreased appetite—Bleomycin—lymphatic system cancer	0.000367	0.000862	CcSEcCtD
Allopurinol—Myalgia—Vincristine—lymphatic system cancer	0.000367	0.000862	CcSEcCtD
Allopurinol—Infection—Carmustine—lymphatic system cancer	0.000366	0.00086	CcSEcCtD
Allopurinol—Vomiting—Fludarabine—lymphatic system cancer	0.000366	0.00086	CcSEcCtD
Allopurinol—Convulsion—Mitoxantrone—lymphatic system cancer	0.000364	0.000855	CcSEcCtD
Allopurinol—Rash—Fludarabine—lymphatic system cancer	0.000363	0.000853	CcSEcCtD
Allopurinol—Dermatitis—Fludarabine—lymphatic system cancer	0.000363	0.000852	CcSEcCtD
Allopurinol—Hypertension—Mitoxantrone—lymphatic system cancer	0.000363	0.000852	CcSEcCtD
Allopurinol—Pain—Bleomycin—lymphatic system cancer	0.000361	0.000848	CcSEcCtD
Allopurinol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000361	0.000848	CcSEcCtD
Allopurinol—Headache—Fludarabine—lymphatic system cancer	0.000361	0.000848	CcSEcCtD
Allopurinol—Myalgia—Mitoxantrone—lymphatic system cancer	0.000357	0.00084	CcSEcCtD
Allopurinol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000357	0.00084	CcSEcCtD
Allopurinol—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000355	0.000833	CcSEcCtD
Allopurinol—Discomfort—Mitoxantrone—lymphatic system cancer	0.000353	0.00083	CcSEcCtD
Allopurinol—Oedema—Vincristine—lymphatic system cancer	0.000352	0.000827	CcSEcCtD
Allopurinol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000352	0.000827	CcSEcCtD
Allopurinol—Anorexia—Carmustine—lymphatic system cancer	0.000351	0.000826	CcSEcCtD
Allopurinol—Infection—Vincristine—lymphatic system cancer	0.00035	0.000821	CcSEcCtD
Allopurinol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000348	0.000818	CcSEcCtD
Allopurinol—Confusional state—Mitoxantrone—lymphatic system cancer	0.000346	0.000812	CcSEcCtD
Allopurinol—Nervous system disorder—Vincristine—lymphatic system cancer	0.000345	0.000811	CcSEcCtD
Allopurinol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000345	0.000809	CcSEcCtD
Allopurinol—Hypotension—Carmustine—lymphatic system cancer	0.000344	0.000809	CcSEcCtD
Allopurinol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000343	0.000805	CcSEcCtD
Allopurinol—Oedema—Mitoxantrone—lymphatic system cancer	0.000343	0.000805	CcSEcCtD
Allopurinol—Nausea—Fludarabine—lymphatic system cancer	0.000342	0.000804	CcSEcCtD
Allopurinol—Infection—Mitoxantrone—lymphatic system cancer	0.00034	0.0008	CcSEcCtD
Allopurinol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00034	0.000799	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000336	0.000789	CcSEcCtD
Allopurinol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000336	0.000788	CcSEcCtD
Allopurinol—Urticaria—Bleomycin—lymphatic system cancer	0.000335	0.000788	CcSEcCtD
Allopurinol—Anorexia—Vincristine—lymphatic system cancer	0.000335	0.000788	CcSEcCtD
Allopurinol—Body temperature increased—Bleomycin—lymphatic system cancer	0.000334	0.000784	CcSEcCtD
Allopurinol—Insomnia—Carmustine—lymphatic system cancer	0.000333	0.000783	CcSEcCtD
Allopurinol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000333	0.000782	CcSEcCtD
Allopurinol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000331	0.000778	CcSEcCtD
Allopurinol—Paraesthesia—Carmustine—lymphatic system cancer	0.000331	0.000778	CcSEcCtD
Allopurinol—Hypotension—Vincristine—lymphatic system cancer	0.000329	0.000773	CcSEcCtD
Allopurinol—Somnolence—Carmustine—lymphatic system cancer	0.000328	0.00077	CcSEcCtD
Allopurinol—Anorexia—Mitoxantrone—lymphatic system cancer	0.000327	0.000767	CcSEcCtD
Allopurinol—Ataxia—Methotrexate—lymphatic system cancer	0.000327	0.000767	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000321	0.000753	CcSEcCtD
Allopurinol—Decreased appetite—Carmustine—lymphatic system cancer	0.00032	0.000753	CcSEcCtD
Allopurinol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00032	0.000752	CcSEcCtD
Allopurinol—Insomnia—Vincristine—lymphatic system cancer	0.000318	0.000748	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000318	0.000748	CcSEcCtD
Allopurinol—Paraesthesia—Vincristine—lymphatic system cancer	0.000316	0.000742	CcSEcCtD
Allopurinol—Pain—Carmustine—lymphatic system cancer	0.000315	0.000741	CcSEcCtD
Allopurinol—Constipation—Carmustine—lymphatic system cancer	0.000315	0.000741	CcSEcCtD
Allopurinol—Breast disorder—Methotrexate—lymphatic system cancer	0.000314	0.000738	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000313	0.000735	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000312	0.000734	CcSEcCtD
Allopurinol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000311	0.000731	CcSEcCtD
Allopurinol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000308	0.000723	CcSEcCtD
Allopurinol—Decreased appetite—Vincristine—lymphatic system cancer	0.000306	0.000719	CcSEcCtD
Allopurinol—Somnolence—Mitoxantrone—lymphatic system cancer	0.000305	0.000716	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000304	0.000714	CcSEcCtD
Allopurinol—Feeling abnormal—Carmustine—lymphatic system cancer	0.000304	0.000714	CcSEcCtD
Allopurinol—Asthenia—Bleomycin—lymphatic system cancer	0.000303	0.000712	CcSEcCtD
Allopurinol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000302	0.000709	CcSEcCtD
Allopurinol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000301	0.000708	CcSEcCtD
Allopurinol—Constipation—Vincristine—lymphatic system cancer	0.000301	0.000707	CcSEcCtD
Allopurinol—Pain—Vincristine—lymphatic system cancer	0.000301	0.000707	CcSEcCtD
Allopurinol—Asthma—Methotrexate—lymphatic system cancer	0.0003	0.000705	CcSEcCtD
Allopurinol—Pruritus—Bleomycin—lymphatic system cancer	0.000299	0.000702	CcSEcCtD
Allopurinol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000298	0.0007	CcSEcCtD
Allopurinol—Eosinophilia—Methotrexate—lymphatic system cancer	0.000297	0.000698	CcSEcCtD
Allopurinol—Pain—Mitoxantrone—lymphatic system cancer	0.000293	0.000689	CcSEcCtD
Allopurinol—Constipation—Mitoxantrone—lymphatic system cancer	0.000293	0.000689	CcSEcCtD
Allopurinol—Body temperature increased—Carmustine—lymphatic system cancer	0.000291	0.000685	CcSEcCtD
Allopurinol—Abdominal pain—Carmustine—lymphatic system cancer	0.000291	0.000685	CcSEcCtD
Allopurinol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000288	0.000676	CcSEcCtD
Allopurinol—Pancytopenia—Methotrexate—lymphatic system cancer	0.000285	0.00067	CcSEcCtD
Allopurinol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000282	0.000663	CcSEcCtD
Allopurinol—Dysuria—Methotrexate—lymphatic system cancer	0.000281	0.00066	CcSEcCtD
Allopurinol—Neutropenia—Methotrexate—lymphatic system cancer	0.000281	0.00066	CcSEcCtD
Allopurinol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00028	0.000658	CcSEcCtD
Allopurinol—Abdominal pain—Vincristine—lymphatic system cancer	0.000278	0.000654	CcSEcCtD
Allopurinol—Body temperature increased—Vincristine—lymphatic system cancer	0.000278	0.000654	CcSEcCtD
Allopurinol—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000277	0.00065	CcSEcCtD
Allopurinol—Urticaria—Mitoxantrone—lymphatic system cancer	0.000272	0.00064	CcSEcCtD
Allopurinol—Hypersensitivity—Carmustine—lymphatic system cancer	0.000272	0.000638	CcSEcCtD
Allopurinol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000271	0.000636	CcSEcCtD
Allopurinol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000271	0.000636	CcSEcCtD
Allopurinol—Vomiting—Bleomycin—lymphatic system cancer	0.000269	0.000631	CcSEcCtD
Allopurinol—Drowsiness—Methotrexate—lymphatic system cancer	0.000268	0.000629	CcSEcCtD
Allopurinol—Depression—Methotrexate—lymphatic system cancer	0.000267	0.000627	CcSEcCtD
Allopurinol—Rash—Bleomycin—lymphatic system cancer	0.000266	0.000626	CcSEcCtD
Allopurinol—Dermatitis—Bleomycin—lymphatic system cancer	0.000266	0.000625	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000265	0.000624	CcSEcCtD
Allopurinol—Asthenia—Carmustine—lymphatic system cancer	0.000264	0.000621	CcSEcCtD
Allopurinol—Stomatitis—Methotrexate—lymphatic system cancer	0.000261	0.000613	CcSEcCtD
Allopurinol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00026	0.000611	CcSEcCtD
Allopurinol—Hypersensitivity—Vincristine—lymphatic system cancer	0.000259	0.000609	CcSEcCtD
Allopurinol—Sweating—Methotrexate—lymphatic system cancer	0.000257	0.000603	CcSEcCtD
Allopurinol—Haematuria—Methotrexate—lymphatic system cancer	0.000255	0.0006	CcSEcCtD
Allopurinol—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000253	0.000595	CcSEcCtD
Allopurinol—Epistaxis—Methotrexate—lymphatic system cancer	0.000253	0.000593	CcSEcCtD
Allopurinol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000252	0.000593	CcSEcCtD
Allopurinol—Asthenia—Vincristine—lymphatic system cancer	0.000252	0.000593	CcSEcCtD
Allopurinol—Diarrhoea—Carmustine—lymphatic system cancer	0.000252	0.000593	CcSEcCtD
Allopurinol—Nausea—Bleomycin—lymphatic system cancer	0.000251	0.000589	CcSEcCtD
Allopurinol—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00025	0.000587	CcSEcCtD
Allopurinol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000246	0.000578	CcSEcCtD
Allopurinol—Dizziness—Carmustine—lymphatic system cancer	0.000244	0.000573	CcSEcCtD
Allopurinol—Haemoglobin—Methotrexate—lymphatic system cancer	0.000242	0.000568	CcSEcCtD
Allopurinol—Diarrhoea—Vincristine—lymphatic system cancer	0.000241	0.000566	CcSEcCtD
Allopurinol—Haemorrhage—Methotrexate—lymphatic system cancer	0.00024	0.000565	CcSEcCtD
Allopurinol—Hepatitis—Methotrexate—lymphatic system cancer	0.00024	0.000565	CcSEcCtD
Allopurinol—Pharyngitis—Methotrexate—lymphatic system cancer	0.000239	0.00056	CcSEcCtD
Allopurinol—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000237	0.000558	CcSEcCtD
Allopurinol—Urethral disorder—Methotrexate—lymphatic system cancer	0.000236	0.000553	CcSEcCtD
Allopurinol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000234	0.000551	CcSEcCtD
Allopurinol—Vomiting—Carmustine—lymphatic system cancer	0.000234	0.000551	CcSEcCtD
Allopurinol—Dizziness—Vincristine—lymphatic system cancer	0.000233	0.000547	CcSEcCtD
Allopurinol—Rash—Carmustine—lymphatic system cancer	0.000232	0.000546	CcSEcCtD
Allopurinol—Dermatitis—Carmustine—lymphatic system cancer	0.000232	0.000546	CcSEcCtD
Allopurinol—Visual impairment—Methotrexate—lymphatic system cancer	0.000232	0.000544	CcSEcCtD
Allopurinol—Headache—Carmustine—lymphatic system cancer	0.000231	0.000543	CcSEcCtD
Allopurinol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000227	0.000534	CcSEcCtD
Allopurinol—Eye disorder—Methotrexate—lymphatic system cancer	0.000225	0.000528	CcSEcCtD
Allopurinol—Tinnitus—Methotrexate—lymphatic system cancer	0.000224	0.000526	CcSEcCtD
Allopurinol—Vomiting—Vincristine—lymphatic system cancer	0.000224	0.000526	CcSEcCtD
Allopurinol—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000223	0.000524	CcSEcCtD
Allopurinol—Rash—Vincristine—lymphatic system cancer	0.000222	0.000521	CcSEcCtD
Allopurinol—Dermatitis—Vincristine—lymphatic system cancer	0.000222	0.000521	CcSEcCtD
Allopurinol—Headache—Vincristine—lymphatic system cancer	0.00022	0.000518	CcSEcCtD
Allopurinol—Nausea—Carmustine—lymphatic system cancer	0.000219	0.000514	CcSEcCtD
Allopurinol—Vomiting—Mitoxantrone—lymphatic system cancer	0.000218	0.000512	CcSEcCtD
Allopurinol—Immune system disorder—Methotrexate—lymphatic system cancer	0.000217	0.00051	CcSEcCtD
Allopurinol—Rash—Mitoxantrone—lymphatic system cancer	0.000216	0.000508	CcSEcCtD
Allopurinol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000216	0.000507	CcSEcCtD
Allopurinol—Chills—Methotrexate—lymphatic system cancer	0.000216	0.000507	CcSEcCtD
Allopurinol—Headache—Mitoxantrone—lymphatic system cancer	0.000215	0.000504	CcSEcCtD
Allopurinol—Alopecia—Methotrexate—lymphatic system cancer	0.000212	0.000499	CcSEcCtD
Allopurinol—Mental disorder—Methotrexate—lymphatic system cancer	0.000211	0.000495	CcSEcCtD
Allopurinol—Malnutrition—Methotrexate—lymphatic system cancer	0.000209	0.000492	CcSEcCtD
Allopurinol—Nausea—Vincristine—lymphatic system cancer	0.000209	0.000491	CcSEcCtD
Allopurinol—Dysgeusia—Methotrexate—lymphatic system cancer	0.000205	0.000481	CcSEcCtD
Allopurinol—Nausea—Mitoxantrone—lymphatic system cancer	0.000204	0.000478	CcSEcCtD
Allopurinol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000194	0.000456	CcSEcCtD
Allopurinol—Anaemia—Methotrexate—lymphatic system cancer	0.000193	0.000454	CcSEcCtD
Allopurinol—Malaise—Methotrexate—lymphatic system cancer	0.000189	0.000443	CcSEcCtD
Allopurinol—Vertigo—Methotrexate—lymphatic system cancer	0.000188	0.000442	CcSEcCtD
Allopurinol—Leukopenia—Methotrexate—lymphatic system cancer	0.000187	0.00044	CcSEcCtD
Allopurinol—Convulsion—Methotrexate—lymphatic system cancer	0.000181	0.000426	CcSEcCtD
Allopurinol—Myalgia—Methotrexate—lymphatic system cancer	0.000178	0.000418	CcSEcCtD
Allopurinol—Arthralgia—Methotrexate—lymphatic system cancer	0.000178	0.000418	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000177	0.000416	CcSEcCtD
Allopurinol—Discomfort—Methotrexate—lymphatic system cancer	0.000176	0.000413	CcSEcCtD
Allopurinol—Confusional state—Methotrexate—lymphatic system cancer	0.000172	0.000404	CcSEcCtD
Allopurinol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000171	0.000401	CcSEcCtD
Allopurinol—Infection—Methotrexate—lymphatic system cancer	0.00017	0.000399	CcSEcCtD
Allopurinol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000167	0.000393	CcSEcCtD
Allopurinol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000167	0.000393	CcSEcCtD
Allopurinol—Skin disorder—Methotrexate—lymphatic system cancer	0.000166	0.00039	CcSEcCtD
Allopurinol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000165	0.000388	CcSEcCtD
Allopurinol—Anorexia—Methotrexate—lymphatic system cancer	0.000163	0.000382	CcSEcCtD
Allopurinol—Hypotension—Methotrexate—lymphatic system cancer	0.00016	0.000375	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000156	0.000365	CcSEcCtD
Allopurinol—Insomnia—Methotrexate—lymphatic system cancer	0.000154	0.000363	CcSEcCtD
Allopurinol—Paraesthesia—Methotrexate—lymphatic system cancer	0.000153	0.00036	CcSEcCtD
Allopurinol—Somnolence—Methotrexate—lymphatic system cancer	0.000152	0.000357	CcSEcCtD
Allopurinol—Dyspepsia—Methotrexate—lymphatic system cancer	0.00015	0.000353	CcSEcCtD
Allopurinol—Decreased appetite—Methotrexate—lymphatic system cancer	0.000148	0.000349	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000147	0.000346	CcSEcCtD
Allopurinol—Pain—Methotrexate—lymphatic system cancer	0.000146	0.000343	CcSEcCtD
Allopurinol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000141	0.000331	CcSEcCtD
Allopurinol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00014	0.000328	CcSEcCtD
Allopurinol—Urticaria—Methotrexate—lymphatic system cancer	0.000136	0.000319	CcSEcCtD
Allopurinol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000135	0.000317	CcSEcCtD
Allopurinol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000135	0.000317	CcSEcCtD
Allopurinol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000126	0.000296	CcSEcCtD
Allopurinol—Asthenia—Methotrexate—lymphatic system cancer	0.000123	0.000288	CcSEcCtD
Allopurinol—Pruritus—Methotrexate—lymphatic system cancer	0.000121	0.000284	CcSEcCtD
Allopurinol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000117	0.000274	CcSEcCtD
Allopurinol—Dizziness—Methotrexate—lymphatic system cancer	0.000113	0.000265	CcSEcCtD
Allopurinol—Vomiting—Methotrexate—lymphatic system cancer	0.000109	0.000255	CcSEcCtD
Allopurinol—Rash—Methotrexate—lymphatic system cancer	0.000108	0.000253	CcSEcCtD
Allopurinol—Dermatitis—Methotrexate—lymphatic system cancer	0.000108	0.000253	CcSEcCtD
Allopurinol—Headache—Methotrexate—lymphatic system cancer	0.000107	0.000251	CcSEcCtD
Allopurinol—Nausea—Methotrexate—lymphatic system cancer	0.000101	0.000238	CcSEcCtD
